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Objective: Hypertension, diabetes, dyslipidemia, and obesity are associated with preclinical 
alterations in cognition and brain structure; however, this often comes from studies of 
comprehensive risk scores or single isolated factors. We examined associations of empirically-
derived cardiovascular disease risk factor domains with cognition and brain structure.  
Methods: 124 adults (age~59.8+13.1;41% African American;50% women) underwent 
neuropsychological and cardiovascular assessments and structural MRI. Principal component 
analysis of 9 cardiovascular disease risk factors resulted in a four-component solution 
representing 1-cholesterol, 2-glucose dysregulation, 3-metabolic dysregulation, and 4-blood 
pressure. Separate linear regression models for learning, memory, executive functioning and 
attention/information processing were performed with all components entered at once, adjusting 
for age, sex, and education.  MRI analyses included whole brain cortical thickness and tract-
based fractional anisotropy adjusted for age and sex.  
Results: Higher blood pressure associated with poorer learning (B=-0.19;p=0.019), memory 
(B=-0.22;p=0.005), and executive functioning performance (B=-0.14;p=0.031), and lower 
cortical thickness within the right lateral occipital lobe. Elevated glucose dysregulation 
associated with poorer attention/information processing performance (B=-0.21;p=0.006) and 
lower fractional anisotropy in the right inferior and bilateral superior longitudinal fasciculi. 
Cholesterol was associated with higher cortical thickness within left caudal middle frontal 
cortex. Metabolic dysfunction was positively associated with right superior parietal lobe, left 
inferior parietal lobe and left precuneus cortical thickness.  
Conclusions: Cardiovascular domains associated with distinct cognitive, grey, and white matter 
alterations and distinct age groups. Future longitudinal studies may assist in identifying 
vulnerability profiles that may be most important for individuals with multiple cardiovascular 
disease risk factors. 
 
 
 
 
Key Words: cardiovascular disease risk factors, blood pressure, glucose, metabolic, cortical 
thickness, diffusion tensor imaging; white matter integrity 
Acronyms: CVD-RF = cardiovascular disease risk factors; BMI = body mass index; DTI = 
diffusion tensor imaging; FA = fractional anisotropy; HC = healthy controls; SBP = systolic 
blood pressure; DBP = diastolic blood pressure; Chol = cholesterol; GluDys = glucose 
dysregulation; MetabDys = metabolic dysregulation; BP = blood pressure; HbA1c = hemoglobin 
A1c; PCA = principal component analysis; LRN = learning; MEM = memory; EF = executive 
function; AIP = attention and information processing; CVLT-II = California Verbal Learning 
Test-II; WMS-III = Wechsler Memory Scales-III; TMT = Trail Making Test; WAIS-III = 
Wechsler Adult Intelligence Scale-III; GLM = general linear model; FWHM = full width half 
maximum; QDEC = Query, Design, Estimate, Contrast; TFCE = threshold free cluster 
enhancement; ILF = inferior longitudinal fasciculus; SLF = superior longitudinal fasciculi 
 
  
 
 
 
 
Introduction  
Cardiovascular disease risk factors (CVD-RFs) including hypertension, dyslipidemia, 
diabetes, and obesity increase the likelihood of stroke, heart failure, and mortality (1). CVD-RFs 
also have a deleterious impact on cognition and brain aging. In fact, all are independent risk 
factors for cognitive decline and dementia (2,3). Given their frequent comorbidity, CVD-RFs 
representing distinct pathophysiological processes including hypertension-related reductions in 
vasodilatory capacity of cerebral arterioles (4) or increases in CNS inflammatory responses 
secondary to diabetes (5) are often clustered together into a single risk score when investigating 
brain/behavior relationships (6). These scores have contributed significantly to our understanding 
that, even in mid-life, higher overall CVD-RF burden is associated with increased risk for 
dementia in later life (3). While risk scores are advantageous for examining cumulative burden, 
they present limitations for understanding contributions of distinct CVD-RF domains (7). 
Advancing our understanding of not only the comorbid impact but also the distinct contributions 
CVD-RF domains have on brain structure and cognition may assist in identifying ‘vulnerability 
profiles’ that may be monitored in affected individuals. 
CVD-RF domains may have diverse and potentially antagonistic impact on gray matter 
morphology. Elevations in systolic and diastolic blood pressure have been associated with 
diffuse cortical thinning of the frontal, temporal, and occipital lobes, whereas higher cholesterol 
levels including total and LDL cholesterol and triglycerides have been associated with increased 
cortical thickness within frontal, temporal, and parietal lobes (8–11). In contrast, glucose 
dysregulation (as measured by such metrics as fasting glucose, hemoglobin A1c and diabetes 
diagnosis) and body mass index (BMI) have been weakly and inconsistently related to cortical 
thickness with results primarily involving frontal, anterior cingulate, temporal, and occipital 
regions (9–12). These investigations often looked at particular CVD-RFs and/or diagnoses in 
 
 
 
 
isolation (8,11,12), very few took a CVD-RF domain approach to investigate blood pressure, 
short and longer-term glucose control, ‘good’ and ‘bad’ cholesterol, etc. within one study (9,10).  
Furthermore, given that CVD-RFs predict cognitive decline (2,3) it is unclear how their 
divergent and often mixed relationship (8–12) with cortical morphology relates to cognition.  
CVD-RF domains also have heterogeneous associations with white matter integrity as 
measured by diffusion tensor imaging (DTI). The most widely used metric of white matter 
integrity (13) is DTI-derived fractional anisotropy (FA). FA alterations have been extensively 
linked with CVD-RFs.  Individuals with hypertension and diabetes have been shown to have 
lower FA than controls, with hypertension preferentially affecting posterior brain regions and 
diabetes impacting more anterior brain regions (14,15). BMI has been positively and negatively 
associated with regional FA (16,17) as have serum cholesterol levels (18,19). While lower FA 
has long been associated with cognitive decline in healthy aging (20); fewer studies have 
explored the role of these CVD-RF-associated FA alterations on cognition. Lower FA has been 
associated with poorer memory, executive function, and processing speed in both diabetes and 
untreated hypertension (21,22); further research incorporating more CVD-RF domains is 
warranted.  
Our study aim was to examine the association of multiple CVD-RF domains with 
cognition and brain structure. We examined the associations of CVD-RF profiles with cognition, 
grey and white matter in a sample of ethnically diverse, community-dwelling adults. Exploring 
the relationship of CVD-RFs to cognition in conjunction with grey and white matter integrity 
may provide insight (23) into the associations of brain/behavior and CVD-RFs (20). We first 
examined CVD-RFs and cognition, hypothesizing that higher (systolic and diastolic) blood 
pressure and glucose dysregulation measured using glucose and hemoglobin A1c would be 
associated with poorer memory, executive function, and attention/information processing. We 
 
 
 
 
then examined associations of CVD-RFs on regional grey and white matter, hypothesizing that 
higher blood pressure would be associated with lower cortical thickness, whereas higher 
cholesterol measures would be associated with greater cortical thickness. Furthermore, we 
hypothesized that elevated blood pressure would be associated with diminished FA in posterior 
brain regions, whereas increased glucose dysregulation would be associated with lower FA in 
anterior regions. Finally, we assessed whether CVD-RF related grey and white matter alterations 
correlated with CVD-RF associated cognitive profiles. 
Methods 
Participants  
Healthy controls (HCs) were identified from a larger program of research investigating 
aging, diabetes and depression approved by the University of Illinois at Chicago Institutional 
Review board and conducted in accordance with the Declaration of Helsinki. HCs provided 
written informed consent at enrollment. As previously described (6), HCs, aged 30 years and 
older (range=30-89), were recruited from the community between 10/2009-08/2012 and 
underwent an initial telephone screening to rule-out neurological and/or Axis 1 disorders, head 
injury or loss of consciousness, substance abuse/dependence, and/or psychotropic medication 
use. Upon successful completion of the telephone screen, study staff including board 
eligible/certified psychiatrists conducted a more detailed in person screening. HC status was 
confirmed if: 1) Mini-Mental State Examination (24) scores were >24, 2) there was an absence 
of current and/or past psychiatric symptoms as assessed by the Structured Clinical Interview for 
DSM-IV and 3) Hamilton Depression Rating Scale scores were <8.  
Of 124 eligible participants (Table 1), 43 (34.7%) met criteria for diabetes (non-fasting 
glucose>200 mg/dl or anti-diabetic mediation use) (25), a rate higher than the Illinois state 
average (23.8%) (26) and likely attributable to active recruitment of individuals with diabetes in 
 
 
 
 
the larger research. Seventy participants were hypertensive (systolic blood pressure [SBP]>140 
mmHg, diastolic blood pressure [DBP]>90 mmHg, or antihypertensive medication use) (27), 54 
met criteria for obesity (BMI>30 kg/m2) (28), 40 had hypercholesterolemia (total 
cholesterol>240 mg/dl or lipid lowering medication use) (29), and 27 did not met criteria for any 
of these conditions. Forty-two participants were on anti-diabetic medications, 50 were on 
antihypertensives, and 36 were on lipid lowering medications.  
CVD-RF Assessment  
One reading of brachial SBP and DBP were obtained with the participant sitting upright 
using an automated device (Welch Allyn, model 300, Welch Allyn Inc., Arden, NC) and 
appropriate cuff size. Weight in kilograms and height in centimeters were collected to calculate 
BMI. A non-fasting blood sample was obtained by venipuncture to determine plasma 
concentrations of glucose, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, 
and hemoglobin A1c (HbA1c). Cholesterol and HbA1c values have been documented to be 
minimally affected by normal food consumption (30).  
In order to allow for the consideration of CVD-RF domains without treating any one 
CVD-RF in isolation at the expense of another, we took our lead from the literature on studies of 
biological determinants of cerebrovascular health (8,9). As suggested by the literature (8,9), 
CVD-RF metrics of interest (SBP, DBP, BMI, glucose, total cholesterol, inverted HDL-
cholesterol, LDL-cholesterol, triglycerides, and HbA1c) were submitted to a PCA with varimax 
rotation to empirically determine the CVD-RF metrics that had high shared variance (e.g., SBP 
and DBP; glucose and HbA1c) and to control for multiple comparisons.  
Similar to previous research using this technique (8,9), our PCA resulted in four 
orthogonal factors that explained 78.0% variance (minimum eigenvalue=1; Table 2) representing 
Cholesterol (Chol; Component #1), Glucose Dysregulation (GluDys; Component #2), Metabolic 
 
 
 
 
Dysregulation (MetabDys; Component #3), and Blood Pressure (BP; Component #4). While 
consistent with prior research (9), our MetabDsy loadings were more robust, likely due to the 
omission of previously documented (9) low-loading creatine from our analyses. PCA marker 
variables guided the creation of domain scores to represent CVD-RFs with the highest shared 
variance per Component (e.g., Component 4: SBP and DBP; Component 2: glucose and HbA1c) 
(31). Raw scores for the highest loadings per Component (Table 2) were transformed into 
standardized z-scores based on the study sample’s mean and standard deviation and averaged to 
create BP, GluDys, MetabDys, and Chol domain scores. 
Neuropsychological Assessment  
Conducted by a trained research assistant and described in detail elsewhere (6), cognitive 
domains were calculated by averaging z-scores within each construct tested: (1) Learning (LRN): 
immediate recall from the California Verbal Learning Test-II (CVLT-II) Trials 1-5 (32) and the 
Wechsler Memory Scales-III (WMS-III) Logical Memory-I and Visual Reproduction-I (33); (2) 
Memory (MEM): CVLT-II long delay free recall (32), WMS-III Logical Memory-II and Visual 
Reproduction-II (33); (3) Executive Function (EF): Trail Making Test (TMT) Part B time to 
completion (34)  (reversed), Delis-Kaplan Executive Function System category switching total 
(35), Stroop Interference score (36), Wechsler Adult Intelligence Scale-III (WAIS-III) Digit 
Span Backwards raw score (37), Self-Ordered Pointing Task total errors (38) (reversed); (4) 
Attention and Information Processing (AIP): TMT Part A time to completion (34) (reversed), 
Stroop Color and Word raw scores (36), WAIS-III Digit-Symbol Coding raw score (37). 
Cronbach’s alphas revealed adequate internal consistency (LRN=0.75, MEM=0.75, EF=0.73, 
AIP=0.84). 
 
 
 
 
 
 
MRI Acquisition 
Whole brain MRI data in the axial plane were collected on a Philips Achieva 3T scanner 
(Philips Medical Systems, the Netherlands) using an 8-channel sensitivity encoding head coil. 
Anatomical image data were collected using MPRAGE (FOV=240mm, contiguous slices=134, 
TR/TE=8.4/3.9ms, flip angle=8°, voxel size=1.1×1.1×1.1mm3). DTI was obtained aligned to the 
anterior commissure-posterior commissure line, using a single-shot spin-echo echo-planar 
imaging sequence (FOV=240mm, contiguous slices=67, TR/TE=6,994/71ms, flip angle=90°, 
voxel size=0.83×0.83×2.2mm3, 32 isotropically distributed diffusion-weighted directions with 
b=700s/mm2, and one B0 images with no diffusion sensitization). Scanning time was reduced to 
~4 minutes using a SENSE parallel imaging technique with a factor of 2.5. 
Of the 124 subjects with available cognitive and cardiovascular data, 86 had T1 images. 
Reasons for unavailable T1 data included: claustrophobia=11; BMI=4; metallic implants=3; 
scanner problems=19; poor image quality=1. Twenty-four did not complete DTI due to time 
constraints and another 9 were removed for poor quality images (DTI n=53). Individuals with 
available MRI data were older than those without MRI data (61.7+12.6 versus 55.6+13.2; 
p=.017); groups did not differ in education or sex. 
Image Processing   
All MRI data was visually examined for quality. This inspection included an examination 
for artifacts from movement or other causes, such as space-occupying or other focal lesions, 
including stroke and other gross neuroanatomical abnormalities. As outlined above, 10 
participants were excluded based on this inspection.  
Cortical thickness quantification was conducted in FreeSurfer Version 5.3.0 
(http://surfer.nmr.mgh.harvard.edu/). Following motion correction and skull stripping, thickness 
measurements were derived at each vertex along the reconstructed surface by computing the 
 
 
 
 
shortest distance between the outer cortical (pial) surface and grey/white matter border (39,40). 
These measurements were mapped onto each participant’s inflated cortical surface and checked 
for quality control by viewing individual images in tkmedit and tksurfer. A spherical averaging 
procedure was implemented to average thickness measurements across participants.  
DTI analysis, implemented in FSL v4.1.9 (http:/www.fmrib.ox.ac.uk/fsl), used FMRIB’s 
Diffusion Toolbox and Tract-Based Spatial Statistics (41). FA images underwent motion 
correction and skull stripping, normalization to the 1mm3 MNI152 stereotaxic space by 
implementing a nonlinear registration of each participant’s FA image to the FSL FA template 
and then applying an affine transformation to the MN1152 template – images were then visually 
inspected for errors in processing and/or distortion. Normalized FA images were averaged to 
create a mean FA map.  A mean FA skeleton was derived by applying a 0.2 threshold (41) and 
images were then visually inspected to ensure that the major tracts were well aligned to the 
skeleton.  Each participant’s FA data was projected onto the group skeleton to identify the 
highest local FA value and then applied to the skeleton.  
 
Statistical Analysis 
Associations between CVD-RF and cognition domains were assessed using IBM SPSS 
Statistics 22 (IBM Corp, Armonk, NY). Separate linear regression models (p<0.05) assessed 
each cognitive domain score individually (4 models) with all CVD-RF domain scores entered at 
once, adjusting for age, sex, and education. Additional adjustments for race, smoking status 
(current smoker: yes/no) and treatment effects (presence/absence of medication use for 
hypertension, diabetes and/or hypercholesterolemia) were also considered. Given the age range 
of our sample (30-89 years), we explored age as a moderator variable by adding an interaction 
term between significant CVD-RF domains and age as appropriate.  
 
 
 
 
The relationship between individual CVD-RF domains and cortical thickness was 
evaluated using a general linear model (GLM) at each vertex in the cortical mantle adjusting for 
age and sex using the Query, Design, Estimate, Contrast (QDEC) interface in FreeSurfer 
(www.surfer.nmr.mgh.harvard.edu; 42). Maps were smoothed with a 15mm full width half 
maximum (FWHM) Gaussian kernel, a more conservative threshold than prior relevant studies 
(9,10). Correction for multiple comparisons was performed with a cluster-wise procedure using 
Monte Carlo Null-z simulation method within the QDEC processing stream (43). For each 
model, 10,000 iterations of the stimulation were performed using a threshold of 1.3 (p<0.05). 
Mean cortical thickness in identified clusters was extracted within QDEC. In supplementary 
regression analyses, associations between individual regions of interest (ROIs) derived from the 
FreeSurfer atlas and CVD-RF domains as well as individual CVD-RF variables were assessed 
adjusting for age and sex. 
Associations between CVD-RF domains and FA, adjusting for age and sex, were 
assessed using regression models adjusted for age and sex.  Five thousand permutations were 
performed and cluster-based thresholding correction was implemented with threshold free cluster 
enhancement (TFCE) (44).  Statistical maps were then thresholded at p<0.001 and clusters sizes 
larger than 100 voxels were identified.  The anatomical location of significant clusters was 
identified using JHU ICBM-DTI-81 White Matter Labels and JHU White Matter Tractography 
(45) and mean FA values were extracted using FSL.  
Due to the truncated MRI sample, we examined the association between CVD-RF related 
morphological alterations, cortical thickness and FA clusters significantly associated with CVD-
RFs, defined and extracted as described above, with their respective CVD-RF cognitive 
associates using two-sided Pearson’s correlations (p<0.05) in SPSS. We also ran more stringent 
 
 
 
 
mediation (46) and indirect mediation analyses with bootstrapping using Preacher and Hayes 
methods  (47,48).  
Results  
Cognition– In separate cognitive models with all cardiovascular domains (BP, GluDys, Chol and 
MetabDys) entered simultaneously adjusting for age, sex and education, only BP domain scores 
were significantly and negatively associated with LRN (B=-0.19,SE=0.08;p=0.019) and MEM 
(B=-0.22,SE=0.07;p=0.005) performance. In contrast, BP as well as GluDys domain scores 
negatively associated with EF (BP: B=-0.14,SE=0.06;p=0.031; GluDys: B=-
0.11,SE=0.06;p=0.058); however, only the BP domain score reached significance (Table 3).  
Only GluDys domain scores significantly and negatively associated with poorer AIP (B=-
0.21,SE=0.07;p=0.006). No associations were observed for Chol or MetabDys. Results remained 
unchanged with further adjustments for race, smoking status and treatment effects except the BP 
and EF association was no longer significant.  
Exploring age as a moderator variable resulted in a significant age X BP interaction for 
LRN (p=0.027) and MEM (p=0.014) only; there were no significant age x GluDys interactions 
(all p-values>0.65). After adjusting for all covariates including race, smoking status and 
treatment effects, only the age X BP interaction for MEM remained significant (p=0.048). A 
follow-up Johnson-Neyman plot revealed a cut-point of significance occurring for the 
conditional effect of BP on MEM such that individuals <64.4 years old showed a significant 
association between BP and MEM (all p-values<0.050) while individuals >64.4 years of age did 
not (all p-values>0.072). 
Cortical Thickness– Higher BP domain scores were associated with lower cortical thickness in 
the right lateral occipital lobe controlling for age and sex (Figure 1a). No significant associations 
between cortical thickness and GluDys were observed (Table 4). Chol domain scores positively 
 
 
 
 
associated with cortical thickness within the left caudal medial frontal cortex after adjustment for 
age and sex (Figure 1b). Higher MetabDys domain scores were associated with higher cortical 
thickness measures in the right superior parietal lobe, left inferior parietal lobe, and left 
precuneus after adjustments for age and sex (Figure 1b). Additional adjustments for race, 
smoking status and treatment effects did not alter these results. For completeness, FreeSurfer 
cortical thickness ROIs as analyzed individually is represented in Supplemental Table I with 
regressions between individual CVD-RFs that comprised each domain score and results of these 
individual analyses shown in Supplemental Table II.  
 An initially significant age X BP interaction for the right lateral occipital lobe adjusting 
for age and sex (p<0.001) did not remain significant after adding race, smoking status and 
treatment effects to the model (p=0.791). Exploring age as a moderator variable did not reveal 
any significant age X Chol or age X MetabDys interactions regardless of adjustments (all p-
values>0.110).  
DTI tractography–After adjustment for age and sex, higher GluDys domain scores associated 
with lower FA in the right inferior longitudinal fasciculus (ILF) and bilateral superior 
longitudinal fasciculi (SLF; Figure 2). No other CVD-RF domain scores associated with FA in 
models adjusted for age and sex. Additional adjustments for race, smoking status and treatment 
effects did not alter our results.  
 Exploring age as a moderator variable revealed significant age X GluDys interactions for 
all identified white matter tracts listed when only age and sex were in the model (all p-
values>0.044). Only the age X GluDys interaction in the right SLF model remained significant 
after adding race, smoking status and treatment effects to the model (p=0.001). Johnson-Neyman 
plots revealed a cut-point of significance occurring for the conditional effect of GluDys on right 
SLF FA with individuals <56.4 years of age showing a significant association between GluDys 
 
 
 
 
and FA in the right SLF (all p-values<0.050) and individuals >56.4 years of age not showing this 
association. 
Neuroimaging and Cognition–We extracted the cortical thickness and FA cluster measures 
associated with CVD-RF domain scores to determine whether these clusters significantly 
correlated with their relevant CVD-RF cognitive associates. For example, LRN, MEM and EF 
correlates to BP were subjected to two-tailed Pearson’s correlations with the lateral occipital 
cortical thickness cluster (also associated with BP); no cognitive domains correlated with this 
thickness measure. When considering the white matter tracts significantly correlated with 
GluDys, EF (a trending correlation with GluDys) was positively associated with right ILF FA 
values [r(df=51)=0.30,p=0.027] and bilateral SLF values [left: r(df=51)=0.32,p=0.020; right: 
r(df=51)=0.33,p=0.014] while AIP scores significantly related to GluDys positively correlated 
with right SLF FA values [r(df=51)=0.27,p=0.048]. Indirect mediation analyses with 
bootstrapping did not corroborate these results, i.e., no mediation or indirect pathway results 
were significant.  
Discussion  
The overarching message from this research is that CVD-RF domains had more divergent than 
convergent influences on cognition and brain structure. For example, BP and GluDys domains 
were more strongly associated with cognition than Chol and MetabDys domains. Additionally, 
BP, Chol and MetabDys were associated with cortical thickness either negatively (BP) or 
positively (Chol and MetabDys), while only GluDys related to (lower) FA. Similarly, only 
GluDys-related FA alterations associated with poorer cognitive functioning suggesting this was 
the most consistent of our brain/behavior relationship findings. While these results may highlight 
the unique information derived by the examination of empirically derived CVD-RF domains, 
when combined with our results using age as a moderator variable, this study highlights the 
 
 
 
 
importance of considering how age may influence brain/behavior associates of CVD-RFs – an 
area of increased interest across multiple CVD-RFs (49–51). 
  Only BP and GluDys emerged as salient associates of cognition. Specifically, higher BP 
associated with poorer LRN, MEM, and EF while greater GluDys associated with poorer AIP 
and poorer EF (albeit a non-significant trend). These findings are consistent with a systematic 
review of the literature that showed hypertension and diabetes display a consistent detrimental 
impact on cognition whereas obesity and dyslipidemia have weak and variable effects (52). This 
may be due to the age of participants across studies, i.e., mid- versus late-life (52), and/or the 
grouping of obesity and dyslipidemia – variables increasingly seen to be distinct (8). Our results 
also indicate that continuous blood pressure and glucose measurements are negatively associated 
with cognition regardless of a diagnosis of hypertension and/or diabetes. Given that continuous 
measures incorporate pre-clinical levels of disease known to be detrimental to brain health 
(17,53), our results may be early support for such recent recommendations as lowing the 
‘optimal’ SBP to <120mmHg (54). While further research is needed to fully determine the 
inflection points beyond which cognition is negatively impacted by BP or glucose, this study and 
others (55) suggest focusing on particular age ranges, e.g., individuals less than age 65 when 
considering BP, may facilitate this work. 
Cardiovascular domains had distinct and competing influences on cortical thickness. 
Higher BP related to lower cortical thickness in posterior regions, while higher Chol was related 
to greater cortical thickness in more anterior regions. Higher MetabDys also associated with 
greater cortical thickness, however, in more posterior, e.g., parietal regions. While cholesterol 
and metabolic-related results regarding cortical thickness may not be intuitive, other studies 
report similar findings (8,9,56). In fact, these studies advocate that BMI and lipids may not be 
consistently related to each other but instead, may be independent CVD-RFs (8), they may also 
 
 
 
 
require a non-linear approach to understanding their brain-behavior relationships. Additionally, 
grey matter measures vary in the literature, introducing differences between cortical thickness 
and grey matter volume that may influence CVD-RF associations, e.g., cortical thickness is more 
vulnerable to environmental exposures while both measures have distinct genetic influences. 
Genetic factors link cholesterol levels in the peripheral and central nervous systems; this may 
differentially impact associations made between genetic regulation of circulating cholesterol and 
alterations in grey as well as white matter morphology (18) further influencing our results.   
Elevations in BP were negatively associated with cortical thickness in the lateral occipital 
cortex, in line with studies demonstrating that hypertension induces cortical degradation in 
posterior regions including the parietal and occipital lobe, areas typically preserved in healthy 
aging (15). This may be due, in part, to the fact that BP elevations can diminish blood brain 
barrier integrity, which disrupts nutrient delivery and propagates neuronal damage, potentially 
resulting in cortical thinning (53,57).  Furthermore, chronic elevations in BP can reduce the 
vasodilatory capacity of the cerebral arterioles by increasing media thickness and narrowing the 
lumen (58). Subsequent reductions in cerebral blood flow may result in hypoperfusion and 
induce neuronal damage and grey matter atrophy (42).  
 GluDys was the only factor associated with TBSS-derived FA values and FA 
subsequently correlated with the cognitive domains shown to be related to GluDys; the only 
white matter findings related to CVD-RFs and their relevant CVD-RF cognitive associates. 
Some GluDys-related white matter associates were driven by younger participants, thus, the wide 
30-89 age range of our sample may have precluded replication of previously reported BP and FA 
associations (15). In contrast, and consistent with other studies (14,17), higher GluDys was 
associated with lower FA in the right ILF and SLF, bilaterally – key white matter tracts 
connecting posterior to more anterior regions of brain to facilitate higher-level cognitive 
 
 
 
 
functions. Elevations in glucose dysregulation may impact FA by propagating pro-inflammatory 
cytokines (59) capable of crossing the blood brain barrier (60), and instigating a local CNS 
inflammatory response characterized by activation of microglial cells (61). Activated microglia, 
in turn, may impede the development and migration of oligodendrocyte progenitor cells (62), 
disrupting myelin production and diminishing white matter integrity as well as the successful 
relay of information to perform executive functioning and attention/information processing tasks. 
Future work focusing on the role of CVD-RFs, particularly glucose, on myelin degradation may 
assist in determining the underlying etiology of our findings (63).  
While this study examined a broad range of cardiovascular, cognitive, and brain 
morphology factors, limitations exist. Consistent with prior literature (8,9), we utilized PCA to 
create CVD-RF domains consisting of factors with high shared variance. While this approach is 
efficacious for creating empirically defined groups of highly similar variables, reducing 
redundancy, and diminishing multiple comparisons, BMI loaded onto both the GluDys and 
MetabDys domains – albeit with lower values than any other variable loading in the PCA. This 
may suggest that BMI is either a multidimensional variable and/or one that did not exert as 
strong a contribution as other CVD-RFs in our PCA. Future studies should incorporate more 
direct assessments of adiposity such as those provided by dual-energy x-ray absorptiometry 
scanning. Our cross-sectional design precludes determination of causation, making longitudinal 
studies necessary. Additionally, larger sample sizes will be necessary to empirically examine the 
interplay between cortical thickness and white matter alterations (23). The neuroimaging and 
cognition mediation analyses and assessment of indirect effects may have suffered from a 
truncated neuroimaging sample making our call for larger sample sizes even more germane. 
These analyses may also have suffered from a limited number of cognitive domains, i.e., a 
 
 
 
 
visuospatial/visuoperceptual component may have related to BP and its lateral occipital 
associates.   
DTI-derived FA reflects diverse morphological changes such as alterations in 
myelination, axonal density, inflammation, and edema (13). While FA may be divided into axial 
and radial diffusivity, many argue that these measures are not only influenced by inflammation 
and edema, they are highly correlated and may not reflect axonal loss (i.e., axial diffusivity) and 
myelin degradation (i.e., radial diffusivity) in isolation (13,63,64). Neuroimaging techniques 
including multi-component relaxometry (64), which eliminate the influence of inflammation and 
edema, may provide greater insight into underlying etiological factors driving white matter 
associates to CVD-RFs including white matter perfusion and demyelination (63). Future studies 
should compare the various microstructural metrics for axonal loss and myelin degradation both 
to each other as well as to CVD-RF profiles to better understand the underlying neuroanatomy 
driving the results of this study. Contrary to previous studies (15), elevations in BP were not 
related to FA. This may be due, in part, to the fact that we only obtained one BP recording as 
opposed to the recommended minimum of two (65) that would have reduced variability inherent 
in a single measurement. Having said that, previous studies show that early elevations in BP may 
impact the cortical mantle with white matter damage emerging later as chronic hypoperfusion 
ensues (53); unfortunately we did not have the sample size to divide our group by age-decades to 
investigate this possibility. Finally, although cluster-based thresholding procedures to adjust for 
multiple comparisons are standard in the literature, these procedures may still result in an 
inflated Type-I error (66). 
Similar to their impact on the peripheral nervous system (67), CVD-RFs may induce 
perturbations across multiple physiological pathways, resulting in distinct yet phenotypic brain 
alterations that may ultimately contribute to pathological aging and dementia. Given that CVD-
 
 
 
 
RFs are modifiable, and optimal control recommendations continue to gravitate toward a more 
conservative approach (54), understanding their distinct and overlapping associations on brain 
aging in early, mid-, and late-life as distinct time periods may help highlight the beneficial 
effects of lowering levels of cardiovascular risk at particular points across the lifespan.  
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Figure Legends 
Figure 1. Cortical thickness associations between (A) BP and right lateral occipital; (B) Chol and 
left caudal medial frontal; (C) MetabDys and left inferior parietal; (D) MetabDys and left 
precuneus; (E) MetabDys and right superior parietal NOTE: Whole brain cortical thickness 
results derived from FreeSurfer. Maps were smoothed with a 15mm full width half maximum 
Gaussian kernel and correction for multiple comparisons was performed using the Monte Carlo 
Null-z simulation (p<0.05). All analyses have been adjusted for age and sex. Red indicates 
negative associations with cortical thickness and yellow indicates positive associations with 
cortical thickness. 
Figure 2. TBSS results in red overlayed on the mean white matter tract skeleton (in green) 
derived from FSL using non-parametric permutation testing and cluster-based thresholding 
correction (p<0.001, cluster size>100 voxels). Significant cluster voxels associated with GluDys 
and fractional anisotropy adjusted for age and sex are depicted by the arrows pointing to the right 
inferior longitudinal fasciculus (ILF) and the right and left superior longitudinal fasciculus 
(SLF).  
 
 
Table I: Sample characteristics  
 Cognitive 
Sample (n=124) 
Neuroimaging 
Sample (n=86) 
p-value 
DEMOGRAPHICS    
Age, years 59.8+13.1 61.7+12.6 0.31 
Education, years 15.6+2.7 15.9+2.8 0.55 
Sex (M:F) 62:62 43:43 0.56 
Race (Caucasian:African 
American:Other) 
  62:51:11 51:28:7 0.69 
MMSE 28.9+1.2 29.0+1.1 0.42 
CARDIOVASCULAR RISK 
FACTORS 
  p-value 
Systolic blood pressure, mmHg 132.4+15.2 133.1+13.7 0.64 
Diastolic blood pressure, mmHg 79.6+9.5 80.3+10.0 0.61 
Body mass index, kg/m2 29.9+7.7 28.2+6.1 0.18 
Total cholesterol, mg/dl 186.6+44.6 184.8+42.6 0.95 
LDL cholesterol, mg/dl 103.2+39.1 99.2+34.9 0.62 
HDL cholesterol, mg/dl 57.7+19.1 61.0+19.6 0.17 
Triglycerides, mg/dl 128.2+67.0 122.3+64.9 0.52 
Glucose, mg/dl 103.4+29.5 101.3+23.3 0.94 
HbA1c, % 6.3+1.2 6.1+0.9 0.41 
Note: All p>0.05. All values represent mean+standard deviation unless otherwise noted. 
M:F=male:female, MMSE=Mini-Mental State Examination, HbA1c=hemoglobin A1c 
Table II: Varimax rotated factor matrix from PCA 
 Component 1 Component 2 Component 3 Component 4 
Total 
Cholesterol 
 0.990 -0.049 -0.052 -0.042 
LDL Cholesterol  0.954  0.030  0.045  0.075 
Glucose  0.001  0.902  0.014  -0.121 
Hemoglobin 
A1c 
-0.063  0.889  0.239  0.080 
Triglycerides   0.123  0.002  0.828 -0.140 
HDL 
Cholesterol 
-0.269  0.175  0.794  0.151 
Body Mass 
Index 
 0.124  0.422  0.521  0.122 
Systolic Blood 
Pressure 
-0.046 -0.022  0.020  0.854 
Diastolic Blood 
Pressure 
 0.075  0.008  0.019  0.855 
Eigenvalue  2.367  1.982  1.544  1.125 
Note: Minimum eigenvalue extraction=1. 
 
 
Table III: Regression results for the association between cardiovascular risk factor and cognitive 
domains 
 Learning 
 
  
β, SE, (p-
value) 
Memory 
 
 
β, SE, (p-
value) 
Executive 
Function 
 
β, SE, (p-
value) 
Attention/ 
Information 
Processing 
β, SE, (p-
value) 
Cholesterol  -0.008  
0.071 
(0.91) 
 0.046  
0.068 
(0.50) 
 0.011   
0.057 
(0.84) 
 0.031    
0.070 
(0.66) 
Glucose -0.088  
0.075 
(0.24) 
-0.076  
0.071 
(0.29) 
-0.114   
0.060 
(0.058) 
-0.209  
0.074 
(0.006)* 
Metabolic -0.115  
0.094 
(0.22) 
-0.116  
0.090 
(0.20) 
 0.017   
0.075 
(0.82) 
 0.089    
0.093 
(0.34) 
Blood Pressure -0.193  
0.081 
(0.019)* 
-0.224  
0.077 
(0.005)* 
-0.142  
0.065 
(0.031)* 
-0.153  
0.080 
 (0.060) 
Note: *p<0.050, analyses were adjusted for age, education, and sex.  
Table IV: Significant clusters of cortical thickness associated with cardiovascular risk factor 
domain scores 
 Region Cluster Size 
(mm2) 
Max Z X, Y, Z 
Talairach 
Coordinates 
Cholesterol Left Caudal 
Middle Frontal 
1450.9  3.377 -38.3, 9.4, 49.3 
Metabolic Right Superior 
Parietal  
7117.6  3.899 22.8, -40.9, 57.8 
Left Inferior 
Parietal 
4817.1  3.222 -39.3, -70.0, 
34.6 
Left Precuneus 1969.9  3.812 -6.8, -59.5, 41.8 
Blood Pressure Right Lateral 
Occipital 
1699.7 -3.644 43.8, -77.8, -6.2 
NOTE: Whole brain results adjusted for age and sex derived from Freesurfer. Maps were 
smoothed with a 15mm FWHM Gaussian kernel and corrected for multiple comparisons using 
the Monte Carlo Null-z simulation (p<0.050). 
 
 
Supplementary Table I: Multiple linear regression results for the association between cardiovascular risk factor component scores and 
cortical thickness regions of interest 
 
 
Cholesterol                
β, SE, (p-value) 
Glucose                        
β, SE, (p-value) 
Metabolic                     
β, SE, (p-value) 
Blood Pressure           
β, SE, (p-value) 
Caudal Anterior Cingulate L -0.023, 0.017, (0.19) 0.000, 0.017, (0.99) -0.014, 0.021, (0.50) 0.004, 0.020, (0.84) 
R -0.010, 0.016, (0.51) 0.001, 0.016, (0.96) 0.006, 0.019, (0.73) -0.001, 0.018, (0.94) 
          Caudal Middle Frontal L 0.018, 0.006, (0.003)* -0.010, 0.006, (0.12) -0.005, 0.008, (0.47) 0.012, 0.007, (0.092) 
R 0.005, 0.006, (0.39) -0.009, 0.006, (0.11) -0.004, 0.007, (0.59) 0.010, 0.006, (0.10) 
Cuneus L 0.003, 0.006, (0.61) 0.000, 0.006, (0.98) 0.006, 0.007, (0.41) 0.003, 0.007, (0.67) 
R -0.001, 0.006. (0.90) 0.000, 0.006. (0.99) 0.002, 0.007, (0.83) -0.003, 0.007, (0.65) 
Entorhinal  L 0.018, 0.018, (0.30) -0.014, 0.018, (0.42) 0.001, 0.022, (0.95) 0.002, 0.020, (0.92) 
R -0.010, 0.022, (0.67) 0.002, 0.022, (0.94) -0.038, 0.027, (0.16) 0.033, 0.025, (0.19) 
Fusiform   L 0.008, 0.006, (0.20) -0.004, 0.006, (0.54) -0.005, 0.008, (0.48) 0.001, 0.007, (0.87) 
R 0.012, 0.007, (0.10) -0.007, 0.007, (0.36) -0.008, 0.009, (0.36) -0.012, 0.008, (0.13) 
Inferior Parietal L 0.000, 0.006, (0.97) 0.012. 0.005, (0.036)* 0.011, 0.007, (0.095) -0.030, 0.006, (0.11) 
R 0.007, 0.006, (0.22) 0.001, 0.006, (0.81) -0.002, 0.007, (0.81) -0.007, 0.007, (0.31) 
Inferior Temporal L 0.010, 0.007, (0.15) -0.007, 0.007, (0.30) -0.014, 0.008, (0.076) -0.006, 0.008, (0.43) 
R -0.003, 0.007, (0.67) 0.001, 0.007, (0.89) -0.009, 0.009, (0.32) -0.015, 0.008, (0.072) 
Lateral Occipital L 0.006, 0.006, (0.29) 0.008, 0.006, (0.17) 0.005, 0.007, (0.50) -0.006, 0.007, (0.40) 
R 0.006, 0.006, (0.34) 0.007, 0.006, (0.27) -0.006, 0.007, (0.42) -0.041, 0.007, (0.041)* 
Lateral  Orbitofrontal L 0.008, 0.007, (0.28) -0.011, 0.007, (0.14) -0.036, 0.008, (<0.001)* 0.005, 0.008, (0.53) 
R 0.000, 0.007, (0.99) -0.009, 0.007, (0.24) -0.016, 0.009, (0.068) 0.007, 0.008, (0.43) 
Lingual L 0.001, 0.005, (0.82) -0.005, 0.005, (0.34) 0.000, 0.006, (0.99) -0.001, 0.006, (0.90) 
R 0.004, 0.006, (0.53) 0.000, 0.006, (0.93) -0.003, 0.007, (0.69) 0.005, 0.007, (0.48) 
Medial Orbitofrontal  L 0.003, 0.009, (0.78) -0.007, 0.009, (0.46) -0.025, 0.011, (0.023)* 0.000, 0.010, (0.99) 
R -0.009, 0.011, (0.42) -0.016, 0.011, (0.16) -0.035, 0.013, (0.007)* -0.006, 0.012, (0.614) 
Middle Temporal L 0.002, 0.006, (0.75) -0.010, 0.006, (0.088) -0.018, 0.007, (0.009)* -0.012, 0.006, (0.068) 
R 0.002, 0.006, (0.70) -0.003, 0.006, (0.66) -0.011, 0.008, (0.17) -0.015, 0.007, (0.039)* 
Parahippocampal L 0.025, 0.017, (0.14) -0.023, 0.017, (0.17) -0.032, 0.020, (0.12) -0.024, 0.019, (0.21) 
R 0.008, 0.015, (0.62) -0.014, 0.015, (0.37) -0.020, 0.019, (0.28) -0.009, 0.017, (0.59) 
Parsopercularis L -0.001, 0.006, (0.86) -0.012, 0.005, (0.029)* -0.011, 0.007, (0.095) 0.001, 0.006, (0.93) 
R 0.009, 0.006, (0.17) -0.006, 0.006, (0.32) -0.009, 0.008, (0.26) -0.005, 0.007, (0.49) 
 
 
 
 
Parsorbitalis  L -0.006, 0.010, (0.53) -0.005, 0.010, (0.65) -0.031, 0.012, (0.009)* 0.002, 0.011, (0.89) 
R -0.014, 0.009, (0.14) 0.002, 0.010, (0.87) -0.007, 0.012, (0.55) 0.013, 0.011, (0.22) 
Parstriangularis L 0.005, 0.007, (0.54) -0.008, 0.007, (0.30) -0.014, 0.009, (0.12) 0.009, 0.008, (0.30) 
R -0.002, 0.008, (0.80) -0.012, 0.008, (0.13) -0.014, 0.009, (0.14) -0.003, 0.009, (0.72) 
Posterior Cingulate L 0.007, 0.007, (0.32) 0.000, 0.007, (0.96) 0.002, 0.008, (0.80) -0.006, 0.008, (0.41) 
R -0.001, 0.007, (0.88) 0.011, 0.007, (0.13) 0.005, 0.009, (0.60) -0.009, 0.008, (0.29) 
Precuneus L 0.004, 0.005, (0.48) 0.006, 0.005, (0.28) 0.011, 0.006, (0.078) 0.001, 0.006, (0.88) 
R 0.006, 0.006, (0.27) 0.009, 0.006, (0.11) 0.003, 0.007, (0.70) -0.004, 0.006. (0.54) 
Rostral Anterior Cingulate  L 0.006, 0.015, (0.71) -0.013, 0.015, (0.40) -0.020, 0.018, (0.27) -0.005, 0.017, (0.77) 
R 0.019, 0.014, (0.18) -0.024, 0.014, (0.091) -0.024, 0.017, (0.17) -0.002, 0.016, (0.90) 
Rostral Middle Frontal L -0.002, 0.005, (0.66) -0.003, 0.005, (0.60) -0.008, 0.006, (0.22) 0.005, 0.006, (0.41) 
R -0.001, 0.005, (0.86) -0.005, 0.005, (0.37) -0.002, 0.006, (0.78) 0.007, 0.006, (0.21) 
Superior Frontal  L 0.003, 0.005, (0.59) 0.003, 0.005, (0.53) 0.006. 0.006, (0.37) 0.003, 0.006, (0.65) 
R 0.010, 0.005, (0.053) 0.001, 0.005, (0.90) 0.002, 0.006, (0.70) 0.013, 0.006, (0.026)* 
Superior Parietal L 0.006, 0.006, (0.35) 0.009, 0.006, (0.14) 0.014, 0.007, (0.061) -0.004, 0.007, (0.60) 
R 0.006, 0.006, (0.28) 0.008, 0.006, (0.16) 0.016, 0.007, (0.015)* -0.001, 0.006, (0.93) 
Superior Temporal L 0.004, 0.007, (0.59) -0.011, (0.007), (0.12) -0.006, 0.008, (0.49) -0.015, 0.008, (0.061) 
R 0.006, 0.007, (0.39) -0.012, 0.007, (0.12) -0.001, 0.009, (0.88) -0.019, 0.008, (0.027)* 
 Note: L=left hemisphere, R=right hemisphere, *p<0.05, All analyses have been adjusted for age, sex 
 
  Supplementary Table II: Association between individual cardiovascular disease risk 
factor components and cortical thickness linear regression results where p was <0.050 
 
a) Cholesterol Domain 
 Total Cholesterol         
β, SE, (p-value) 
LDL Cholesterol       
β, SE, (p-value) 
L. Caudal Middle Frontal 0.002, 0.006, (0.001)* 0.015, 0.006, (0.013)* 
Note: *p<0.05, All analyses have been adjusted for age, sex 
 
b) Glucose domain 
 Glucose                       
β, SE, (p-value) 
HbA1c                        
β, SE, (p-value) 
L. Inferior Parietal 0.011, 0.005, (0.033)* 0.009, 0.005, (0.090) 
L. Parsopercularis -0.010, 0.005, (0.045)* -0.010, 0.005,(0.048)* 
Note: *p<0.05, All analyses have been adjusted for age, sex 
 
c) Metabolic domain 
 Triglycerides                
β, SE, (p-value) 
HDL Cholesterol        
β, SE, (p-value) 
BMI                              
β, SE, (p-value) 
L. Lateral Orbitofrontal -0.024, 0.006,(<0.001)* 0.026, 0.007,(<0.001)* -0.016, 0.007, (0.014)* 
L. Medial Orbitofrontal -0.016, 0.008, (0.052) 0.025, 0.009, (0.007)* -0.006, 0.008, (0.45) 
R. Medial Orbitofrontal -0.025, 0.010, (0.013)* 0.033, 0.011, (0.003)* -0.009, 0.010, (0.37) 
L. Middle Temporal -0.009, 0.005, (0.090) 0.009, 0.006, (0.13) -0.015, 0.005, (0.004)* 
L. Parsorbitalis -0.020, 0.009, (0.030)* 0.023, 0.010, (0.025)* -0.015, 0.009, (0.098) 
R. Superior Parietal 0.008, 0.005, (0.11) -0.013, 0.006,(0.021)* 0.009, 0.005, (0.068) 
Note: *p<0.05, All analyses have been adjusted for age, sex 
 
d) Blood Pressure (BP) domain 
 Systolic BP                  
β, SE, (p-value) 
Diastolic BP                      
β, SE, (p-value) 
R. Lateral Occipital -0.014, 0.006, (0.017)* -0.007, 0.006, (0.23) 
R. Middle Temporal -0.015, 0.006, (0.15)* -0.008, 0.006, (0.23) 
R. Superior Frontal 0.011, 0.005, (0.029)* 0.008, 0.005, (0.093) 
R. Superior Temporal -0.011, 0.007, (0.14) -0.017, 0.007,(0.017)* 
Note: *p<0.050, All analyses have been adjusted for age, sex 
 
 
 
 
 
 
 
Supplementary Table III: Multiple linear regression results for the association between cardiovascular risk factor component scores and diffusion 
tensor imaging regions of interest 
 
 
Cholesterol                
β, SE, (p-value) 
Glucose                        
β, SE, (p-value) 
Metabolic                     
β, SE, (p-value) 
Blood Pressure           
β, SE, (p-value) 
Superior Longitudinal 
Fasciculus 
0.002, 0.001, (0.013)* -0.002, 0.001, (0.014)* 0.000, 0.001, (0.99) 0.000, 0.001, (0.99) 
Superior Longitudinal 
Fasciculus Temporal 
0.002, 0.001, (0.033)* -0.003, 0.001, (0.013)* 0.000, 0.001, (0.82) 0.000, 0.001, (0.91) 
          Cingulum Hippocampus 0.001, 0.001, (0.37) -0.002, 0.001, (0.17) -0.002, 0.002, (0.16) 0.000, 0.001, (0.82) 
Inferior Fronto-Occipital 
Fasciculus  
0.002, 0.001, (0.089) -0.003, 0.001, (0.007)* 0.000, 0.001, (0.92) 0.002, 0.001, (0.24) 
Inferior Longitudinal 
Fasciculus 
0.002, 0.001, (0.23) -0.003, 0.001, (0.087) 0.000, 0.004, (0.97) 0.002, 0.002, (0.15) 
Anterior Thalamic Radiation  0.001, 0.001. (0.45) -0.001, 0.001, (0.16) 0.002, 0.001, (0.13) 0.001, 0.001, (0.15) 
Uncinate Fasciculus  0.003, 0.002, (0.12) -0.003, 0.002, (0.13) -0.001, 0.002, (0.73) -0.001, 0.002, (0.51) 
 Note: *p<0.05, All analyses have been adjusted for age, sex 
 
-  
 
 
 
 
Figure 1. Cortical thickness associations between (A) BP and right lateral occipital; (B) Chol and left caudal medial frontal; (C) 
MetabDys and left inferior parietal; (D) MetabDys and left precuneus; (E) MetabDys and right superior parietal NOTE: Whole brain 
cortical thickness results derived from FreeSurfer. Maps were smoothed with a 15mm full width half maximum Gaussian kernel and 
correction for multiple comparisons was performed using the Monte Carlo Null-z simulation (p<0.05). All analyses have been 
adjusted for age and sex. Red indicates negative associations with cortical thickness and yellow indicates positive associations with 
cortical thickness. 
 
 
 
 
 
 
Figure 2. TBSS results in red overlayed on the mean white matter tract skeleton (in green) derived from FSL using non-parametric 
permutation testing and cluster-based thresholding correction (p<0.001, cluster size>100 voxels). Significant cluster voxels associated 
with GluDys and fractional anisotropy adjusted for age and sex are depicted by the arrows pointing to the right inferior longitudinal 
fasciculus (ILF) and the right and left superior longitudinal fasciculus (SLF).  
 
 
